Skip to main content
Erschienen in: International Urology and Nephrology 3/2011

01.09.2011 | Urology – Original Paper

Percutaneous nephrolithotomy for staghorn kidney stones in elderly patients

verfasst von: Baris Kuzgunbay, Tahsin Turunc, Ozgur Yaycioglu, Aliye Atay Kayis, Umit Gul, Tulga Egilmez, Cem Aygun, Hakan Ozkardes

Erschienen in: International Urology and Nephrology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We retrospectively analyzed the results of percutaneous nephrolithotomy operations for treatment of staghorn kidney stone disease in elderly patients and compared surgical parameters and outcomes with a control group of young adult patients.

Patients and method

Between 2002 and 2010, 300 consecutive patients underwent percutaneous nephrolithotomy operation for treatment of staghorn kidney stone disease. Forty-five of the patients were older than 65 years and considered to be in elderly group. Thirty-seven of the patients were between the ages 18 and 36 years and considered to be the control group. Surgical parameters and outcomes were compared between groups.

Results

There were no significant differences between groups for stone area, operation time, difference in hemoglobin levels before and after surgery, blood transfusion rate, and length of hospital (P = 0.230, P = 0.106, P = 0.395, P = 0.691, and P = 0.690, respectively). Success rates after the operations were 53% in elderly group and 38% in young adult group. The difference for the outcomes of the operations was statistically insignificant (P = 0.365). Thirty-three (73%) of the patients had associated comorbid diseases in elderly group, while no patients had any comorbid disease in control group. Statistical analyses revealed no significant relation between the presence of comorbid diseases or ipsilateral renal surgery with success rate of the operation in the elderly group (P = 0.26 and P = 0.222, respectively).

Conclusions

The management of kidney stone disease by percutaneous nephrolithotomy in elderly patients is an adequate treatment modality even in the presence of complete staghorn calculi, comorbid diseases or previous ipsilateral renal surgery.
Literatur
2.
Zurück zum Zitat Soucy F, Ko R, Duvdevani M et al (2009) Percutaneous nephrolithotomy for staghorn calculi: a single center’s experience over 15 years. J Endourol 23(10):1669–1673PubMedCrossRef Soucy F, Ko R, Duvdevani M et al (2009) Percutaneous nephrolithotomy for staghorn calculi: a single center’s experience over 15 years. J Endourol 23(10):1669–1673PubMedCrossRef
3.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef
4.
Zurück zum Zitat Kandel LB (1990) Treatment of renal calculi in the elderly. Am J Kidney Dis 16:329–331PubMed Kandel LB (1990) Treatment of renal calculi in the elderly. Am J Kidney Dis 16:329–331PubMed
5.
Zurück zum Zitat Stoller ML, Bolton D, St Lezin M, Lawrence M (1994) Percutaneous nephrolithotomy in the elderly. Urology 44:651–654PubMedCrossRef Stoller ML, Bolton D, St Lezin M, Lawrence M (1994) Percutaneous nephrolithotomy in the elderly. Urology 44:651–654PubMedCrossRef
6.
Zurück zum Zitat Sahin A, Atsu N, Erdem E et al (2001) Percutaneous nephrolithotomy in patients aged 60 years or older. J Endourol 15:489–491PubMedCrossRef Sahin A, Atsu N, Erdem E et al (2001) Percutaneous nephrolithotomy in patients aged 60 years or older. J Endourol 15:489–491PubMedCrossRef
7.
Zurück zum Zitat Doré B, Conort P, Irani J, Comité Lithiase de l’Association Française d’Urologie et al (2004) Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases. Prog Urol 14:1140–1145PubMed Doré B, Conort P, Irani J, Comité Lithiase de l’Association Française d’Urologie et al (2004) Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases. Prog Urol 14:1140–1145PubMed
8.
Zurück zum Zitat Jou YC, Lin CT, Shen CH et al (2009) Tubeless percutaneous nephrolithotomy for elderly patients. Urol Int 82:346–349PubMedCrossRef Jou YC, Lin CT, Shen CH et al (2009) Tubeless percutaneous nephrolithotomy for elderly patients. Urol Int 82:346–349PubMedCrossRef
9.
Zurück zum Zitat Anagnostou T, Thompson T, Ng CF et al (2008) Safety and outcome of percutaneous nephrolithotomy in the elderly: retrospective comparison to a younger patient group. J Endourol 22(9):2139–2145PubMedCrossRef Anagnostou T, Thompson T, Ng CF et al (2008) Safety and outcome of percutaneous nephrolithotomy in the elderly: retrospective comparison to a younger patient group. J Endourol 22(9):2139–2145PubMedCrossRef
10.
Zurück zum Zitat Desai M, Jain P, Ganpule A et al (2009) Developments in technique and technology: the effect on the results of percutaneous nephrolithotomy for staghorn calculi. BJU Int 104(4):542–548PubMedCrossRef Desai M, Jain P, Ganpule A et al (2009) Developments in technique and technology: the effect on the results of percutaneous nephrolithotomy for staghorn calculi. BJU Int 104(4):542–548PubMedCrossRef
Metadaten
Titel
Percutaneous nephrolithotomy for staghorn kidney stones in elderly patients
verfasst von
Baris Kuzgunbay
Tahsin Turunc
Ozgur Yaycioglu
Aliye Atay Kayis
Umit Gul
Tulga Egilmez
Cem Aygun
Hakan Ozkardes
Publikationsdatum
01.09.2011
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2011
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9885-6

Weitere Artikel der Ausgabe 3/2011

International Urology and Nephrology 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.